Story at a Glance
- Die Welt, a mainstream media outlet in Germany, revealed that numerous subjects who suffered adverse events, including deaths, during Pfizer’s COVID-19 shot trials were removed from the trial data.
- A person known as “Pfizer subject C4591001 1162 11621327” died three days after receiving the second dose of Pfizer’s COVID shot, reportedly due to stroke and arteriosclerosis; it was deemed unrelated to the shots.
- The U.S. Centers for Disease Control and Prevention (CDC) has since warned that people ages 65 and older who received Pfizer’s updated (bivalent) COVID-19 booster shot may be at increased risk of stroke.
- Die Welt also revealed contradictions in Pfizer documents, adverse events from the shot downplayed, and mass unblinding of study subjects, which wasn’t revealed in a later approval study.
- In November 2020, Pfizer claimed its COVID-19 shot was 95 percent effective against COVID-19, but this was highly misleading and based on flawed methodology, including excluding people who got COVID-19 within 14 days after their first shot.
- Pfizer has profited immensely despite the concerns, earning a record $100 billion in 2022, including $37.8 billion for its COVID-19 shots and $18.9 billion for its antiviral drug Paxlovid.